Table 2.
Specificity of labeling of @CuPs and peptides exhibiting significant binding
| Strong† | Medium‡ | Weak§ | Unlabeled¶ | |
|---|---|---|---|---|
| Viral protein/viruses | ||||
| CMV virions | 71 | 41 | 48 | 224 |
| CMV CP | 0 | 29 | 63 | 292 |
| Buffer | 0 | 0 | 1 | 383 |
| Cuticular peptides | ||||
| Ap2‐01 | 2 | 2 | 4 | 376 |
| pepS | 10 | 4 | 19 | 351 |
| Ap2‐02 | 2 | 1 | 11 | 370 |
| Ap2‐03 | 33 | 36 | 37 | 278 |
| Ap2‐04 | 11 | 1 | 7 | 365 |
| pepL | 2 | 2 | 2 | 378 |
| Ap2‐05 | 18 | 1 | 12 | 353 |
| Ap2‐06 | 14 | 1 | 6 | 363 |
| Ap2‐07 | 6 | 6 | 2 | 372 |
| Ap2‐08 | 2 | 0 | 8 | 374 |
| Ap2‐08 | 2 | 2 | 2 | 378 |
| Ap2‐09 | 3 | 0 | 3 | 378 |
| Buffer | 0 | 0 | 0 | 384 |
†Binding of >12 000 units observed on average.
‡Binding of between 8000 and 12 000 units observed on average.
§Binding of between 3000 and 8000 units observed on average.
¶Binding of <3000 units observed on average.